Male Breast Cancer Terminated Phase 1 / 2 Trials for Doxorubicin (DB00997)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00063934Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast CancerTreatment